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ABSTRACT 
 
A new simple, accurate, precise and 
reproducible Reverse Phase-High Performance Liquid 
Chromatographic method has been developed for the 
simultaneous estimation of Aceclofenac and 
Tizanidine in tablet dosage forms using C18 column 
(Ineretsil, 250 x 4.6 mm, 5 µm) in isocratic mode. The 
mobile phase consisted of acetonitrile, methanol and 
20 mM phosphate buffer adjusted to pH 3.5 in ratio of 
(40:30:30 v/v) with Ultraviolet-Visible detection at 
230 nm. The method was linear over the concentration 
range for aceclofenac120-280 µg/ml and for tizanidine 
2-40 µg/ml. The recoveries of Tizanidine and 
Aceclofenac were found to be in the range of 99.45-
100.61% and 99.56-101.32% respectively. The 
validation of method was carried out using 
International Conference on Harmonization-
guidelines. The described High Performance Liquid 
Chromatographic method was successfully employed 
for the analysis of pharmaceutical formulations 
containing combined dosage form. 
 
Key words: Simultaneous estimation, RP-HPLC, 
Aceclofenac, Tizanidine, ICH guideline 
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INTRODUCTION 
 
Aceclofenac, {2, (2,6dichlorophenyl) amino 
phenyl acetic acid.}, is a phenyl acetic acid derivative 
(Structure 1a) with the improved gastric tolerance and 
is used for relief pain and inflammation in rheumatoid 
arthritis1. Tizanidine is chemically {5, chloro N- (2 
imidozolin 2yl) 2, 1, 3, benzothiadiazol 4- yl amine 
hydrochloride} (Structure 1b), is centrally acting 
skeletal muscle relaxant with central analgesic effect 
and gastric tolerance effect with combination on Non-
Steroidal Anti-Inflammatory Drugs2. A combination 
of these drugs containing Tizanidine and Aceclofenac 
is commercially available by Aceclofenac 100 mg and 
Tizanidine 2 mg for rheumatic disorders. Aceclofenac 
and Tizanidine individually have shown efficacy in 
the treatment of low back pain. But Aceclofenac-
Tizanidine combination was more effective than 
aceclofenac alone and had a favorable safety profile in 
the treatment of acute low back pain3.                                            
 
Literature survey revealed that various 
analytical methods like spectrophotometric, HPLC and 
High Performance Thin Layer Chromatographic 
methods have been reported                                                                                  
for the determination of Aceclofenac and Tizanidine 
from their formulations individually and in 
combination with other drugs4-16. The review of 
literature revealed that no method is yet reported for 
the simultaneous estimation of both the drugs in 
combination. This prompted us to develop simple, 
accurate, precise and sensitive simultaneous 
estimation of Aceclofenac and Tizanidine by RP-
HPLC method. The method was validated as per 
International Conference on Harmonization (ICH) 
guidelines17.  
 
 
 
EXPERIMENTAL PROCEDURE 
 
Drugs and chemicals: 
 
The pharmaceutical grade pure samples of 
Aceclofenac (99.26%) and Tizanidine (99.64%) 
supplied by Healthcare Pharmaceuticals, Pondicherry, 
India. Acetonitrile and methanol HPLC grade 
solvents; all analytical grade solvents obtained from 
E-Merck Ltd, Mumbai, India. Potassium dihydrogen 
orthophosphate Analytical Reagent grade was 
procured from Qualigens Fine Chemical, Mumbai, 
India. The HPLC grade water was obtained from a 
Milli-Q water purification system. 
HPLC apparatus and conditions:  
 
The separation was performed by using 
Ineretsil C18 (250 × 4.6 mm, 5 μm) column on a 
Shimadzu liquid chromatographic system equipped 
with a Shimadzu LC 10 AT VP isocratic solvent 
delivery system, Shimadzu SPD 10A dual wavelength 
absorbance detector and Rheodyne injector with 20 μl 
loop volume.  Mobile Phase consisted of 20 mM 
phosphate buffer (adjusted to pH 4): acetonitrile : 
methanol in ratio of (40:30:30 v/v). The mobile phase 
was prepared freshly, filtered, sonicated before use 
and delivered at a flow rate of 1.0 ml/min. and the 
detector wavelength was set at 230 nm. The injection 
volume was 20 μl (fixed loop). 
 
Stock solutions and standards: 
 
Standard stock solutions were prepared of 
1000 μg/ml of Aceclofenac and Tizanidine, separately 
using mobile phase. From the standard stock solution 
different concentrations of working standard solution 
were prepared ranging from 120-280 μg/ml for 
Aceclofenac and 2-40 μg/ml for Tizanidine.  
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Calibration curve: 
 
The calibration curves were constructed for 
the determination of the linearity and the curves were 
plotted with the concentration range verses area must 
obey Beer’s law. The linearity was evaluated by 
analysis of the serially diluted sample in the range of 
2-40 μg/ml for Tizanidine and 120-280 μg/ml for 
Aceclofenac. An aliquot was injected using mixture of 
20 mM phosphate buffer: acetonitrile: methanol 
(40:30:30 v/v). The 20 μl mixture was injected for the 
estimation under the optimized chromatographic 
conditions. The typical chromatogram was recorded 
for standard as shown in Fig 1. The retention time of 
standard Tizanidine and Aceclofenac were found to be 
4.32 min. and 6.93 min. respectively with a good 
resolution of 14.63. 
 
Analysis of formulations: 
 
Twenty tablets were weighed and finely 
powdered. A quantity equivalent to 20 mg of 
Tizanidine and 100 mg of Aceclofenac were 
transferred to 100 ml volumetric flask and dissolved 
on about 50 ml of mobile phase. The solution was 
ultrasonicated for 10 min and filtered through 
Whatmann filter paper No.41 and the final filtration 
was done in 0.45 micron membrane and volume made 
up to mark with same solvent system. Above solution 
was taken to prepare a dilution of 4 μg/ml of 
Tizanidine and 200 μg/ml of Aceclofenac. The amount 
of drug was determined and three replicate injections 
were done (Table-3). 
 
RESULT AND DISCUSSION 
Method development: 
 
Several tests were performed in order to get 
satisfactory separation-resolution of Aceclofenac and 
Tizanidine in different mobile phases with various 
ratios of organic phase and buffers by using C18 
column. The ideal buffer was used 20mM phosphate 
buffer (pH 4): acetonitrile: methanol in ratio (40:30:30 
v/v) by isocratic elution to obtain satisfactory and 
good resolution. Increasing or decreasing pH of 
mobile phase by ± 0.2 dose not shows significant 
change in retention time of each analyte. The retention 
of Aceclofenac and Tizanidine on analytical column 
was evaluated at a flow rate of 1.0 ml/min. and the 
injection volume was 20 μl. The retention time of 
standard and sample for Aceclofenac and Tizanidine 
were satisfactory with good resolution. 
 
Linearity:  
 
The linearity for HPLC method was determined at six 
concentration levels. The linearity of Aceclofenac and 
Tizanidine were determined by calibration curves and 
the linearity based on the area observed in the range of 
2-40 μg/ml for Tizanidine and 120-280 μg/ml for 
Aceclofenac. The % Relative standard deviation (% 
RSD) of peak area and the retention time was within 
the limit of ±2%.  This indicates that the method was 
system suitable. The reports are tabulated below in 
Table 1. The regression co-efficient value (r2) for 
Aceclofenac and Tizanidine is 0.9996 and 0.9990 
respectively.  
 
Precision: 
 
Precision was measured for both inter and intra-day, 
and checked with repeatability and the % RSD for the 
repeatability was found to be 0.171% to 0.254% and 
0.134% to 0.283% respectively for Aceclofenac and 
Tizanidine. The RSD was found to within the limit 
and tabulated in Table 1. The limit of quantification 
was determined by injecting minimum concentration 
of the drugs. The limit of quantification was found to 
be 50 μg /ml and 0.80 μg/ml for Aceclofenac and 
Tizanidine. 
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Recovery studies:  
The assay procedure was repeated for 
standard and sample six times and mean peak area 
ratio and concentration of drugs were calculated. The 
percentage of individual drugs found in formulation, 
mean and % RSD in formulation were calculated and 
present in Table 2. Recovery study carried out for both 
the drugs was performed by spiking the known 
amount of pure drug in powdered formulations. It is 
usually done by adding 80 %, 100 % and 120 % of the 
pure drug with the formulation taken for analysis. The 
average % recovery for Aceclofenac and Tizanidine 
was found to be 99.57 % to 99.62 % respectively. The 
results are tabulated below in Table 3. 
Specificity and Selectivity: 
Specificity was tested against standard compounds and 
against potential interferences. To determine 
specificity with respect to sample compounds the 
responses of standard and sample solution were 
compared. No interferences were detected at the 
retention times of either Aceclofenac or Tizanidine in 
sample solution.  
The limit of detection (LOD) was determined as 
lowest concentration giving response and limit of 
quantification was determined as the lowest 
concentration analyzed with accuracy method were 
determined by injecting progressively low 
concentrations of the standard solutions using 
developed RP-HPLC method. The limit of detection 
(LOD) for Aceclofenac and Tizanidine was found to 
be 20 μg /ml and 0.40 μg/ml respectively. The limit of 
quantification (LOQ) was 50 μg /ml and 0.80μg/ml for 
Aceclofenac and Tizanidine respectively and reported 
Table 1. 
 
Stability:  
 
In order to demonstrate the stability of both standard 
and sample solutions during analysis, both solutions 
were analyzed over a period of 24 h at room 
temperature. The results show that for both solutions, 
the retention time and peak area of Aceclofenac and 
Tizanidine remained almost similar (% RSD less than 
2.0) and significant degradation within the indicated 
period, thus indicated that both solutions were stable 
for at least 24 h, which was sufficient to complete the 
whole analytical process. 
Table- 1 
 SYSTEM SUITABILITY PARAMETER 
 
PARAMETERS 
 
Aceclofenac  
 
Tizanidine 
Calibration Range (μg /ml) 
Correlation Coefficient(r2) 
Retention time(Min) 
Asymmetry 
Theoretical Plates 
Resolution factor 
Tailing Factor 
Selectivity 
Repeatability %RSD (n=5) 
Limit of quantification (μg /ml) 
120-280 
0.9999 
6.9±0.2 
1.127 
4563 
14.63 
1.36 
-- 
0.246% 
           50 
 
2-40 
0.9998 
4.9±0.2 
1.148 
3269 
--- 
1.12 
1.60 
0.283% 
0.80 
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Table- 2 
 ANALYSIS OF MARKETED FORMULATION 
 
Formulation Aceclofenac  Tizanidine 
Label 
claim 
mg/tab 
Amount 
found* 
mg/tab ± 
RSD 
% assay 
± RSD 
Label 
claim 
mg/tab 
Amount 
found* 
mg/tab ± 
RSD 
% assay 
± RSD 
 
ASMR 
 
 
100 
 
 
101.36±0.369 
   
 
101.36±0.963 
 
2 
 
 
1.96±0.958 
 
 
99.95±0.654 
 
 
* stands for the average reading taken in three readings. 
 
 
 
Table- 3  
RECOVERY STUDIES OF TIZANIDINE AND ACECLOFENAC IN COMBINED DOSAGE FORM 
 
 
 
                                         
Formulation 
Aceclofenac  Tizanidine 
% added  % recovered*  ± 
RSD 
% recovery 
± RSD 
% added  % recovered*   ± 
RSD 
% recovery 
± RSD 
 
 
Brand  
ASMR 
80 
 
79.89±0.423 99.56±0.015 
 
80 
 
79.58±0.589 
 
99.45±0.380 
 
100 
 
99.82±0.892 
 
99.82±0.010 
 
100 
 
100.61±0.632 
 
100.61±0.010 
120 
 
121.21±1.126 
 
101.32±0.065 120 
 
120.58±0.654 
 
100.38±0.221 
 
*Recovery experiment data for Aceclofenac and Tizanidine showing the amount of drug recovered from sample 
solution at each level (n=3), percentage recovery and the average percentage recovery. 
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1 (a): Structure of Aceclofenac 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 (b): Structure of Tizanidine 
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Fig 1:  A Typical Chromatogram for Aceclofenac and Tizanidine 
 
 
 
 
 
Fig 2 (a) Blank 
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Fig 2 (b) Limit of Detection (LOD) of Aceclofenac 20μg/ml 
 
 
 
 
 
Fig 2 (c) Limit of Detection (LOD) of Tizanidine 0.40μg/ml 
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Ruggedness and Robustness: 
 
Ruggedness test was determined between two 
analysts, instruments and columns. Robustness of the 
method was determined by small deliberate changes in 
flow rate, mobile phase pH and mobile phase ratio. 
The content of the drug was not adversely affected by 
these changes as evident from the low value of relative 
standard deviation indicating that the method was 
rugged and robust.  
 
CONCLUSION 
 
A selective, sensitive, precise and accurate method has 
been developed for the analysis of Aceclofenac and 
Tizanidine in Tablet dosage form. Hence the present 
RP-HPLC method is suitable for the quality control of 
the raw materials, formulations, dissolution studies 
and can be employed for bioequivalence studies for 
the same formulation. 
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